1. Azios NG, Dharmawardhane SF. Resveratrol and estradiol exert disparate effects on cell migration, cell surface acting structures and focal adhesion assembly in MDA-MB-231 human breast cancer cells. Neoplasia. 2005. 7:128–140.
Article
2. Banno N, Akihisa T, Tokuda H, Yasukawa K, Taguchi Y, Akazawa H, Ukiya M, Kinura Y, Suxuki T, Nishino H. Anti-inflammatory and antitumor-promotin effects of the triterpene acids from the leaves of Eriobotrya japonica. Biol Pharm Bull. 2005. 25:1995–1999.
3. Cos S, Fernández R, Güézmes A, Sánchez-Barceló EJ. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res. 1998. 58:4383–4390.
4. Festuccia C, Bologna M, Gravina GL, Guerra F, Angelucci A, Villanova I, Millimaggi D, Teti A. Osteoblast conditioned media contain TGF-β and modulate the migration of prostate tumor cells and their interactions with extracellular matrix component. Int J Cancer. 1999. 81:395–403.
Article
5. Festuccia C, Guerra F, D'Acenzo S, Guinciuglio D, Albini A, Bologna M. In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin. Int J Cancer. 1998. 75:418–431.
Article
6. Goodman SL, Vollmer HP, Birchmeier W. Control of cell locomotion: pertubation with an antibody directed against specific glycoproteins. Cell. 1985. 41:1029–1038.
Article
7. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaeonson SA. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol. 2000. 148:779–790.
Article
8. Huang Y, Kim MS, Ratovitski E. Midkine promote tetraspanin-integrin interaction and inuceds FAK-Stat1 alpha pathway contributing to migration/invasivemess of human head and neck squamous cell carcinoma cells. Biochem Biophys Res Commun. 2008. 377:474–478.
Article
9. Ito H, Kobayashi E, Takamatsu Y, Li S, Hatano T, Sakagami H, Kusama K, Satoh K, Sugita D, Shimura S, Itoh Y, Yoshida T. Polyphenols from Eribotrya japonica and their cytotoxicity against human oral cancer cell lines. Chem Pharm Bull. 2000. 48:687–693.
Article
10. Johansson N, Ahonen M, Kajari VM. Matrix metalliproteinases in tumor invasion. Cell Mol Life Sci. 2000. 57:5–15.
11. Kawasaki G, Yanamoto S, Yoshitomi I, Yamada S, Mizuno A. Overexpression of metastasis-associated MTA1 in oral squamous cell carcinomas:correlation with metastasis and invasion. Int J Oral Maxillofac Surg. 2008. 37:1039–1046.
Article
12. Kim E, Kim MS, Rhyu DY, Min OJ, Baek HY, Kim YJ, Kim HA. Hypoglycemic effect of Eryobotrya japonica (E. japonica) in db/db mice. The Korean Journal of Food and Nutrition. 2009. 22:159–165.
13. Kohn EC, Liotta LA. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res. 1995. 55:1856–1862.
14. Liang ZZ, Aquino R, Feo VD, Shimone FD, Pizza C. Polyhaydroxylated triterpene from Eribotrya japonica. Planta Med. 1990. 56:330–332.
15. Meng Q, Goldberf ID, Rosen EM, Fan S. Inhibitory effects of indole-3-carbinol on invasion and migration in human breast cancer cells. Breast Cancer Res Treat. 2000. 63:147–152.
Article
16. Nozato N, Matsumoto K, Uemitsu N. Triterpene from the leaves of Eribotrya japonica. Nat Med (Tokyo). 1994. 48:336.
17. Shaikh FM, Seales EC, Clem WC, Hennessy KM, Zhuo Y, Bellis SL. Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms. Exp Cell Res. 2008. 314:2941–2950.
Article
18. Shimizu M, Uemitsu N, Shirota M, Matsumoto K, Tezuka U. A new triterpene ester from Eribotrya japonica. Chem Pharm Bull. 1996. 44:2181–2182.
19. Song G, Ohashi T, Sakamoto N, Sato M. Adhesive force of human hepatoma HepG2 cells to endothelial cells and expression of E-selectin. Mol Cell Biomech. 2006. 3:61–68.
20. Sun Y, Lu N, Ling Y, Gao Y, Chen Y, Wang L, Hu R, Qi Q, Liu W, Yang Y, You Q, Guo Q. Oroxylin A suppress invasion through down-regulating the expression of matrix metallic proteinase-2/9 in MDA-MB-435 human breast cancer cells. Eur J Pharmacol. 2009. 603:22–28.
Article
21. Tommasi ND, Shimone FD, Pizza C. Cinstituents of Eribotrya japonica : a study of their antiviral properties. J Nat Prod. 1992. 55:1067–1073.
22. Weber GF. Molecular mechanism of metastasis. Cancer Lett. 2008. 270:181–190.
23. Yoneda T, Sasaki A, Mundy GR. Osteolytic bone metastasis in breast cancer. Breast Cancer Res Treat. 1994. 32:73–84.
Article
24. Zheng DQ, Woodard AS, Fronaro M, Tallini G, Languino LR. Prostatic Carcinoma Cell Migration Via αvβ3 integrin is modulated by a focal adhesion kinase pathway. Cancer Res. 1999. 59:1655–1664.